Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VARELISA DSDNA ANTIBODIES (FARR VERSION)

K-Number: K950031 · 1995-03-10

ApplicantElias U.S.A., Inc.
Decision Date1995-03-10
Product CodeLRM
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

VARELISA DSDNA ANTIBODIES (FARR VERSION) is the device name listed in this FDA 510(k) record. The listed applicant is Elias U.S.A., Inc.. It received FDA 510(k) clearance on 1995-03-10 under 510(k) number K950031. The device is classified under product code LRM. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VARELISA DSDNA ANTIBODIES (FARR VERSION)?

VARELISA DSDNA ANTIBODIES (FARR VERSION) is a medical device that received FDA 510(k) clearance on 1995-03-10. The listed applicant is Elias U.S.A., Inc.. The 510(k) number is K950031.

When did VARELISA DSDNA ANTIBODIES (FARR VERSION) receive FDA 510(k) clearance?

VARELISA DSDNA ANTIBODIES (FARR VERSION) received FDA 510(k) clearance on 1995-03-10, under 510(k) number K950031.

Who is the listed applicant for VARELISA DSDNA ANTIBODIES (FARR VERSION)?

The FDA 510(k) record lists Elias U.S.A., Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VARELISA DSDNA ANTIBODIES (FARR VERSION)?

The FDA product code for VARELISA DSDNA ANTIBODIES (FARR VERSION) is LRM.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Elias U.S.A., Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K964385ELIAS ANA-HEP-2K963291VARELISA ANA (4) PROFILEK953873VARELISA HELICOBACTER PYLORI ANTIBODIESK953586VARELISA PR3-ANCAK953587VARELISA MPO-ANCAK951187VARELISA CARDIOLIPIN ABS SCREEN

View all 54 devices →

Related Devices (Code: LRM)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K101319IMMULISA DSDNA ANTIBODY ELISAImmco Diagnostics, Inc.K083381EUROIMMUN ANTI-DSDNA-NCX ELISA (IGG)Euroimmun Us, Inc.K062183FARRZYME HUMAN HIGH AVIDITY ANTI-DSDNA ENZYME IMMUNOASSAY KITThe Binding Site, Ltd.K040811VARELISA SSDNA ANTIBODIES, MODEL 14896Pharmacia Deutschland GmbHK001900ENZYME IMMUNOASSAY ANTI-SSDNA ANTIBODY TESTHelix Diagnostics, Inc.K000477MDI DS-DNA TESTMicro Detect, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑